Стратификация пациентов с гемобластозами и диссеминированными солидными опухолями с использованием модифицированного интегрального показателя качества жизни
Диссертация
Спектр и выраженность симптомов значительно отличаются у пациентов с гемобластозами и диссеминированными солидными опухолями в зависимости от градации снижения модифицированного интегрального показателя качества жизни. Группы больных со значительным и критическим снижением модифицированного интегрального показателя качества жизни характеризуются высокими показателями встречаемости актуальных… Читать ещё >
Список литературы
- Аронов Д. М. Зайцев В.П. Методика оценки качества жизни больных с сердечно-сосудистыми заболеваниями. Кардиология. 2002, 5, стр. 9295
- Ионова Т.И. Качество жизни онкологических больных / Т. И. Ионова, А. А. Новик, Ю. А. Сухонос // Вопросы онкологии. 1998. — Т. 44, № 6. — С. 749−752.
- Новик А.А. Валидация опросника для оценки боли у онкологических больных Brief Pain Inventory / А. А. Новик, Т. И. Ионова, С. А. Калядина // Паллиативная медицина и реабилитация. 2001 № 1 (4). — с. 19.
- Новик А.А. Исследование качества жизни в медицине. Учебное пособие для вузов / А. А. Новик, Т. И. Ионова. М.: Издательский Дом «ГЭОТАР-МЕД», 2004. 297 с.
- Новик А.А. Качество жизни новый критерий эффективности лечения. Вестник Межнационального центра исследования качества жизни. 2004- 3−4:4
- Новик А.А. Концепция исследования качества жизни в медицине. // А. А. Новик, Т. Н. Ионова, П. Каинд. Спб.: ЭЛБИ, 1999, 142 с.
- Ю.Новик А. А. Методология оценки болевого синдрома у онкологических больных / А. А. Новик, Т. Н. Ионова, С. А. Калядина. // Материалы конференции «Паллиативная медицина и качество жизни». -СПб., 2001.-С. 36−54.
- Новик А.А. От концепции исследования качества жизни к теории принятия решения в клинической медицине // Вестник Межнационального центра исследования качества жизни. 2006. — № 78: 20−36.
- Новик А.А. Оценка качества жизни больного в медицине / А. А. Новик, С. А. Матвеев, Т. И. Ионова и др. // Клиническая медицина. 2000. — № 2.-С. 10−13.
- Новик А.А. Оценка симптомов в паллиативной медицине / А. А. Новик, Т. И. Ионова, С. А. Калядина // Материалы конференции «Паллиативная медицина и качество жизни». — Санкт-Петербург, 2001. — С. 26 -33.
- Новик А.А. Оценка симптомов у онкологических больных / А. А. Новик, Т. И. Ионова, С. А. Калядина // Вестник Межнационального центра исследования качества жизни. 2003. № 1−2. С. 79−82.
- Новик А.А. Показатели качества жизни населения Санкт-Петербурга / А. А. Новик, Т. И. Ионова, Б. Гандек, Ю. А. Сухонос, А. В. Киштович, А. А. Цепкова. // Проблемы стандартизации в здравоохранении. 2001. — № 4.- С. 22−31.
- Новик А.А. Руководство по исследованию качества жизни в медицине / А. А. Новик, Т.И. Ионова-М., ОЛМАМедиагруп, 2007, с. 315.
- Новик А.А. Применение опросников для оценки симптомов впаллиативной медицине / А. А. Новик, Т. И. Ионова, М. О. Иванова, С А. Калядина, О. С. Успенская // Материалы конференции «Паллиативная медицина и качество жизни». Санкт-Петербург, 2001. — С. 81−83.
- Новик А.А. Профили симптомов у больных с диссеминированными солидными опухолями и гемобластозами. // Новик А. А., Ионова Т. И., С. А. Калядина С.А., Киштович А. В. Вестник Межнационального центра исследования качества жизни. 2006. № 7−8, с. 37 — 45
- Новик А.А. Руководство по исследованию качества жизни в медицине // А. А. Новик, Т. И. Ионова. Москва: ОЛМА,. — Спб.: Нева, 2002, с. 3 202 007.
- Новик А.А. Современные подходы к исследованию качества жизни в онкологии и гематологии / А. А. Новик, К. М. Абдулкадыров, Ю. К. Янов и др. // Проблемы гематологии и переливания крови. 1999. — № 2.-С. 45−51.
- Осипова Н.А. Фармакотерапия хронического болевого синдрома у онкологических больных. Пособие для врачей. Паллиативная медицина и реабилитация. 1997- 1: 31−41.
- Осипова Н.А. Хронический болевой синдром в онкологии. // Осипова Н. А, Г. А. Новиков, Б. М. Прохоров 1998- М.: «Медицина», с 183.
- Рекомендации FDA для фармацевтической индустрии: использование оценок, сделанных пациентом, при внедрении новой медицинскойпродукции. Вестник Межнационального качества жизни. 2006- 7−8: 153−154.
- Сенкевич Н.Ю. Качество жизни при хронической обструктивной болезни легких // Хронические обструктивные болезни легких // под ред. А. Г. Чучалина. -М. -1998. стр. 171−191
- Шухов B.C. Боль: механизмы формирования, исследование в клинике. Обзорная информация. / B.C. Шухов // Медицина и здравоохранение. Серия: Невропатология и психиатрия. 1990. № 3.- 62.
- Aaronson N.K. A modular approach to quality of life assessment in cancer clinical trials / N.K. Aaronson, M. BuUinger, S.A. Ahmedzai // Recent Results Cancer Res. 1988.-Vol. 111. — P. 231−241.
- Aaronson N.K. Quality of life assessment in clinical trials: methodologic issues / N.K. Aaronson // Control Clin. Trials. 1989. — Vol. 10. -P. 195 208.
- Aistars J. Fatigue in the cancer patient: A conceptual approach to a clinical problem / J. Aistars // Oncol. Nurs. Forum. 1987. — Vol. 14. — P. 25−30.
- Ancoline-lsrael S. The relationship between fatigue and sleep in cancer patients: a review / S. Ancoline-lsrael, P. Moore // Eur. J. Cancer Care. -2001.-Vol. 10.-P. 245−255.
- Andrykowski M. «Returning to normal» following bone marrow transplantation: outcomes, expectations and informed consent / M. Andrykowski M. Brady // BMT. 1995. — Vol. 15. — P. 573−581.
- Andrykowski M. Off-treatment fatigue in breast cancer survivors: acontrolled comparison / M. Andrykowski. S. Curran, C.B. Greiner et al. // J. Behav. Med. -1998. Vol. 21.-P. 1−18.
- Andrykowski M. Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia / M. Andrykowski, M. Brady // Psychosom. Med. 1994. — Vol. 56. P. 432−439.
- Andrykowski M. The quality of life in adult survivors of allogeneic bone marrow transplantation / M. Andrykowski, E. Altmaier, R. Barnett // Transplantation. 1990. Vol. 50. P. 399−406.
- Bacon C.G. The association of treatment-related symptoms with quality of-life outcomes for localized prostate carcinoma patients / C.G. Bacon, E. Giovannucci, M. Testa et al. // Cancer. 2002. Vol. 94, № 3. p. 862−871.
- Baker F. Reintegration after bone marrow transplantation.// Baker F., Zabora J., Polland A. et al./ Cancer Pract 1997−48:190−197.
- Bietz J. Quality of life endpoints in cancer clinical trials: the US Food and drug Administration perspective / J. Bietz, C. Gnecco, R. Justice // J. Natl. Cancer Inst. Monogr. 1996. Vol. 20. P. 7−9
- Bloom J.R. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer // J. Clin. Oncol. 1998. — vol. 25, suppl. 1. — p. 3−8
- Bostrom B. A comparison of pain and health-related quality of life between two groups of cancer patients with differing average levels of pain / B. Bostrom, M. Sandh, D. Lundberg et al. // J. Clinic Nurs. -2003. -Vol. 12. P. 726−735.
- Bottomley A. International Perspective on Health-Related Quality-of-Life Research in Cancer Clinical Trials: The European Organisation for Research and Treatment of Cancer Experience. // JCO, Nov., vol. 25, — 2007, p. 5082−5086.
- Bowling A. Handbook of health research methods // A. Bowling. Ebrahim S., Maidenhead: Open University Press, 2005.
- Bowling A. Measuring Disease: a review of disease-specific quality of life measurement scales / A. Bowling. Philadelphia: Open University Press, 1996. -208 р. Зб. м 43р.
- Broers S. Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study.// Broers S., Kaptein A.A., Le Cessie S. et al. J Psychosom. Res 2000- 48: 11−21
- Budd G.T. Palliative chemotherapy of adult soft tissue sarcomas // Semin. Oncol. — 1995. —Vol. 22, Suppl. 3. — P. 30−34.
- Carol M. Funding Patient-Reported Outcomes in Cancer Clinical Trials // JCO Nov vol. 10, 2007, p. 5100−5105
- Cella D. Measuring quality of life today: methodological aspects. /Cella D., Tulsky D. //Oncology, 1990 .-Vol. 944(5)-P. 29−38.
- Cella D. Fatigue in cancer patients compared with fatigue in the general United States population / D. Cella, J.S. Lai, C.H. Chang et al. // Cancer. -2002,-Vol. 94.-P. 528−538.
- Cella D. Manual: Functional Assessment of Cancer Therapy (FACT) /D.F. Cella.-NY.: Scales, 1992.
- Chang V.T. Quality of life and survival: The role of multidimensional symptom assessment / V.T. Chang, H.T. Thaler, T.A. Polyak et al. // Cancer. -1998.-Vol. 83.-P. 173−179.
- Chang V.T. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment / V.T. Chang, S.S. Hwang, M. Feuerman et al. // Cancer. 2000. Vol. 88, № 5. P. 1175−1183.
- Chao N.J. Dynamic assessment of quality of life after autologous bone marrow transplantation.// Chao N.J., Tierney DK, Bloom JR et al.- Blood. 1992- 80: 825−830
- Chen M.L. Anxiety and depression in Taiwanese cancer patients with and without pain / M.L. Chen, H.K. Chang, C.H. Yeh // J. Adv. Nurs. 2000 -Vol. 32, № 4. -p. 944−951.
- Cherny N. Cancer pain: principles of assessment and syndromes / N. Cherny // Principles and practice of supportive oncology- Eds. A.M. Berger, R. K. Portenoy, D. E. Weissman. -NY: Lippincott-Raven, 1998. P. 3−34.
- Chiu T.Y. Dyspnea and its correlates in Taiwanese patients with terminal cancer / T.Y. Chiu, W.Y. Ни, B.H. Lue et al.// Supp. Care Cancer. -2000.-Vol. 8. P. 311−313.
- Chochinov H.M. Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgments / H.M. Chochinov, K.G. Wilson, M. Enns el al. // Am. J. Psychiatry. 1994. Vol. 151. -P.537−540.
- Ciaramella A. Assessment of depression among cancer patients: the role of pain, cancer type and treatment / A. Ciaramella, P. Poli // Psychooncology. -2001. -Vol. 1*0, № 2. P. 156−165.
- Cleeland C. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling / С Cleeland, Y. Nakamura, T. Mendoza // Pain. 1996. — Vol. 67. — P. 267−73.
- Cleeland C. Measuring and understanding fatigue / C. Cleeland, X. Wang//Oncology. 1999.-Vol. 13.-P. 91−97.
- Cleeland C. Pain assessment: global use of the brief pain inventory / C. Cleeland, K. Ryan // Ann. Acad. Med. Singapore. 1994. — Vol. 23. — № 2. -P. 129−138.
- Cleeland C. Assessing Symptom Distress in Cancer Patients / C.S. Cleeland, T. Mendoza, X.S. Wang et al. // Cancer. 2000. — Vol. 89. — P. 7−13.
- Cleeland C. Cancer-related symptoms. Seminars in Radiation / C.S. Cleeland//Oncology. 2000. — Vol. 10, № 3. — P. 175−190.
- Cleeland C. Pain assessment in cancer / C.S. Cleeland // Effect of cancer on quality of life- Ed. D. Osoba Boca Raton, Fla.: CRC Press, 1991. -P. 293 305.
- Cleeland C. Research in cancer pain: what we know and what we need to know / C.S. Cleeland // Cancer. 1991. Vol. 67, Suppl. — P. 823−827.
- Cleeland C. The impact of pain on the patient with cancer / C.S. Cleeland // Cancer. 1984. Vol. 58, Suppl. — P. 2635−2641.
- Close D.R. Measurement of health-related quality of life: reliability and validity of the SF-36 health survey in patients with cancer / D.R. Close, A.
- Olivarez // Qual. Life Research. 2000. -Vol. 9, № 3. — P. 296.
- Coates A.S. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer// Coates A.S., Gebski V, Signorini D. et al J. Clin. Oncol. — 1992. —№ 10. —P. 1833−1838.
- Coates A.S. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy // Coates A.S., Porzsolt F., Osoba D.- Eur. J. Cancer. 997. vol. 33. P. 1025−1030.
- Coyle N. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life / N. Coyle, J. Adelhardt, K.M. Foley et al. // J. Pain Symptom Manage. 1990. -Vol. 5.-P. 83−93.
- Curt G.A. The impact of fatigue on patients with cancer / G.A. Curt // The Oncologist. 2000. — Vol. 5, Suppl. 2. — P. 9−12.
- Daut R.L. The prevalence and severity of pain in cancer / R.L. Daut, C.S. Cleeland//Cancer. 1982. № 50.- P. 1913−1918.
- Degner L.F. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer / L.F. Degner, J.A. Sloan // J. Pain Symptom Manage. 1995. — Vol. 10. — P. 423−431.
- Derogatis L.R. The prevalence of psychiatric disorders among cancer patients / L.R. Derogatis, G.R. Morrow, J. Fetting el al. // JAMA. 1983. -Vol. 249. P. 751−757.
- Dimeo F. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation // Dimeo F., Bertz H., Lepage E. et al. BMT. 1996. — Vol.18. — P. 1157−1160
- Dimeo F. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high dose chemotherapy // Dimeo F., Fetscher S., Mertelsmann R. et al. Blood. — 1997. — Vol.90. — P. 3390−3394
- Dodd M.J. Symptom clusters and their effect on the functional status of patients with cancer / M.J. Dodd, С Miaskowski, S. Paul // Oncol. Nurs. Forum.-2001.-Vol.28. P. 465−470.
- Donnelly S. The symptoms of advanced cancer / S. Donnelly, D. Walsh // Semin. Oncol. 1995. — Vol. 22, Suppl. 3. — P. 67−72
- Dumontt C. Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen.// Dumontt C., Bastion Y., Felman P. et al. Ann Oncol 1992- 3−639−644
- Dysvik E. Health-related quality of life and pain beliefs among people suffering from chronic pain / E. Dysvik. T.C. Lindstrom, О.J. Eikeland et al. //Pain Manag. Nurs. 2004. Vol. 5, № 2. P. 66−74.
- Edwin P. Rock. Patient-Reported Outcomes Supporting Anticancer Product Approvals // JCO Nov vol. 10, 2007, p. 5094−5099
- Escalante C. A Fatigue clinic in a comprehensive cancer center / C. Escalante, T. Grover// Cancer. 2001. — Vol. 92, Suppl. 6. — P. 1708−1713.
- Escalante C. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world / C.P. Escalanle, C.G. Martin. L.S. Elting el al.//Cancer. 1996. Vol. 78. P. 1314−1319.
- Evans D.R. Factors associated with the psychological well-being of adults with acute leukemia in remission / D.R. Evans, A.B. Thompson, G.B. Browne // J. Clin. Psychol. 1993. — Vol. 49. — P. 153−160.
- Fauser A.A. Guidelines for antiemetic therapy: Acute emesis / A.A. Fauser, M. Fellhauer, M. Hoffmann et al. // Eur. J. Cancer. 1999. — Vol. 35.-P. 361 370.
- Ferrell B. The experience of pain and perceptions of quality of life: validation of a conceptual model / B. Ferrell, M. Grant, G. Padilla et al. // Hosp. J. -1991.- Vol. 7.-P. 9−24.
- Flechtner H. Fatigue and quality of life: lessons from the real world / H. Flechtner, A. Bottomley // Oncologist. 2003. — Vol. 8, Suppl. 1. — P. 5−9.
- Foley K.M. Pain assessment and cancer pain syndromes / K.M. Foley // Oxford Textbook of Palliative Medicine- Eds. D. Doyl, G.C. Hanks, N. McDonald. Oxford: Oxford’University Press. — 1993. — P. 148−165.
- Freishman S.B. Treatment of Symptom Clusters: Pain, Depression and Fatique / S.B. Freishman // J. Natl. Cancer Monogr. 2004. — № 32. — P. 119
- Ger L.P. The prevalence and severity of cancer pain: A study of newly-diagnosed cancer patients in Taiwan / L.P. Ger, S.T. Ho, J.J. Wang et al. // Pain Symptom Manage. 1998. — Vol. 15. P. 285−293.
- Goisis A. Application of a WHO protocol on medical therapy for oncologic pain in internal medicine hospital / A. Goisis, M. Gorini, R. Ratti et al. // Tumori. -1989. Vol. 75. P. 470−472.
- Gondek K., Sagnier P.-Ph., Gilchrist K. et al. Current Status of Patient-Reported Outcomes in Industry-Sponsored Oncology Clinical Trials and Product Labels. // JCO, vol 25 32 (November 10) 2007, p. 5087−5093.
- Grandjean E. Fatigue: its physiological and psychological significance / E. Grandjean//Ergonomics. 1968. Vol.11. P. 427−436.
- Greenwald H.P. The prevalence of pain in four cancers / H.P. Greenwald, J.J. Bonica, M. Bergner // Cancer. 1987. — Vol. 60. — P. 2563−2569.
- Grond S. Assessment of cancer pain: a prospective evaluation in 2266cancer patients referred to a pain service / S. Grand, D. Zech, C.
- Diefenbach et al. // Pain. 1996. -Vol. 64. — P. 107−114.
- Grond S. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic / S. Grand, D. Zech, C. Diefenbach et al. // J. Pain Symptom Manage. 1994. -Vol. 9. — P. 372−382.
- Hays R.D., Users manual for Medical Outcomes Study (MOS) Core measures of health-related quality of life. RAND corporation MR 162-RC (available at www.rand.org)
- Hayabuchi N., Jingu K., Miyoshi M. etal. Radiotherapy and chemotherapy in stage I and II non-Hodgkin's lymphomas of Waldeyer’s ring//J. Jpn.Soc. Cancer Ther. — 1990. —Vol.25. — P. 1428−1436.
- Hetzel-Sesterheim M., Schnabel K., Nestle U. Primary cerebral non-Hodgkin's lymphomas. The results of radiotherapy // Leukemia. 1996. — Vol.10, № 4.-P. 707−712
- Hicks I.E., Lambert M.H., Gerber L.H. et al. Functional outcome updatein patients with soft tissue sarcoma undergoing wide local excision and radiation (abstract) I I Arch. Phys. Med. Rehabil. — 1985. — Vol. 66. — P. 543.
- Hjemstad MJ. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study// Hjemstad MJ, Evensen SA, Kvaloy SO e al J. Clin. Oncol. 1999- 17: 706−718
- Hjemstad M.J. The course of anxiety and depression during fist year after allogeneic or autologous stem cell transplantation.//Hjemstad MJ, Loge J.H. al. J. Bone marrow transplantation 1999- 1219−1228
- Hoerni B. Quality of life during and following radiochemotherapy for Hodgkin’s disease. Evaluation of 60 patients // Bull. Cancer. — 1983. vol. 70, № 4- p. 284−288
- Hopwood P. Psychiatric: morbidity in patients with advanced cancer of the breast: Prevalence measured by two self-rating questionnaires / P. Hopwood, A. Howell, P. Maguirc // Br. J. Cancer. 1991. — Vol. 64. — P. 349−352.
- Hornquist I. Quality of life: concept and assessment /J. Hornquist// Scand. J. Social. Med. 1982. -№ 10. P. 57−61
- Hughes J.E. Depressive illness and lung cancer. I. Depression before diagnosis / J.E. Hughes // Eur. J. Surg. Oncol. 1985 Vol. 11. — P. 15−20.
- Ionova T.I. Fatigue and quality of life (QoL) impairment in advanced cancer / T.I. Ionova, A.A. Novik, A.V. Kishtovich et al. // Clinic. Oncol.-2005. Vol. 23, № 16, Suppl. P. 780.
- Irvine D. Fatigue experienced by healthy individuals / D. Irvine, L. Vincent, N. Bubela et al. // Cancer Nurs. 1994. — Vol. 17. — P. 367−378.
- Jacox A., CarrD.B., Payne R.etal. Management of Cancer Pain. Clinical Practice Guideline № 9 // Rockville: Agency for Health Care Policy and
- Research, U.S. Department of Health and Human Services, Public Health Service, 1994. — Publications № 94−0592.
- Jenkins C.A. Initial demographic, symptom, and medication profiles in patients admitted to continuing palliative care units / C.A. Jenkins, A.W. Taube, K. Turner et al. // J. Pain Symptom Manage. 1998. -Vol. 16.-P. 163−170.
- Jerkeman M. CHOP versus MACOP-B in aggressive lymphoma a Nordic Lymphoma Group randomized trial / Jerkeman M., H. Anderson, E. Cavallin-Stahl et al. //Ann. Oncol. — 1999. — Vol. 10: 1079−1086
- Jerkeman M. Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. / Jerkeman M., Kaasa S., Hjermstad M. et al.// Med Oncol. 2001, vol. 18(1) p. 85−94.
- Johnson JR. Food and Drug Administration requirements for approval of new anticancer drugs / Johnson JR, Temple R. // Cancer Treat Reports. 69, 1985. p. 1155−1157
- Joly F. Late psychosocial sequelae in Hodgkin’s disease survivors: a Franch population-based case-control study // J. Clin. Oncol. 1996. Vol. 14, № 9.-P. 2444−2453
- Kaasa S. Symptom assessment in palliative care: a need for international collaboration / Kaasa S., Havard Loge, Peter Fayers. // J. Clin. Oncol. -2008. Vol.-lO. P. 3867−3873.
- Kind P. The EuroQoL Instrument: an index of health -related quality of life// Quality of life and pharmacoeconomics in clinical trials / Ed. Spilker B. 2nd Edition. — Philadelphia: New-York Lippincott-Raven, 1996. -P.191−201.
- Kornblith A.B. Quality of life assessment of Hodgkin’s disease survivors: a model for cooperative clinical trials // oncology. 1990. — Vol. 4, № 5. -P. 93−101
- Kuo T.T. Symptom distresses and coping strategies in patients with non-small cell lung cancer / T.T. Kuo, F.C. Ma // Cancer Nurs. 2002. — Vol. 25, № 4. -P. 309−317.
- Lee V.C. Defining Quality of Life in Chronic Pain / V. C Lee, J.C. Rowlingson // Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed- Ed. B. Spilker. Philadelphia: Lippincott-Raven Publishers, 1996. -P. 853−864.
- Lerue A.R. Multicentre study of cancer pain and its treatment in France / A.R. Lerue // British J. General Practice. 1995. — Vol. 310. — P. 1034−1037.
- Mainpour C.M. Quality of life end points in cancer clinical trials / CM. Mainpour // National Cancer Institute 1989. Vol. 81. -P. 485−495.
- Malawer M.M. Major amputation done with palliative intent in the treatment of local body complications associated with advanced cancer / Malawer M.M., Buch R.G., Thompson W.E., Sugarbaker P.H. // J. Surg. Oncol. — 1991. — Vol. 47, № 2. — P. 121−130
- Markham A. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications/ Markham A., Bryson H.M. //Drugs. —1995.—Vol. 42, № 2. — P. 232 — 254.
- McCorkle R. Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease / McCorkle R, J. Quint-Benoliel // Soc. Sci.Med. 1983. Vol. 17. P.131−138.
- McCorkle R. The measurement of symptom distress / R. McCorkle // Semin. Oncol. Nurs. 1987 — Vol. 3. — P. 248−256.
- McQuellon R.P. Quality of life in breast cancer patients before and after autologous bone marrow transplantation / R.P. McQuellon, B. Craven, G.B. Russell el al. // Bone Marrow Transplant. 1996. Vol. 18. — P. 579−584.
- McQuellon R.R. Quality of life psychological distress of bone marrow transplant recipients: the «time trajectory» to recovery over the first year / McQuellon R. R, Russell G.B., RamboT.D. // Bone Marrow Transplantation. — 1998. — vol. 21. — P. 477−486.
- Mendoza T.R. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients / T.R. Mendoza, X.S. Hao, C.S. Cleeland // Cancer. 2004. — Vol. 101, № 8.-P.l890−1901.
- Mendoza T.R. The relationship of pain to the most commonly reported symptoms associated with cancer / T.R. Mendoza, C. Chou, C.S. Cleeland // Poster presented at the 9th Annual World Congress on Pain. -Vienna, Austria, 1999.
- Mendoza T.R., Wang X.S., Cleeland C.S. et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory//Cancer. — 1999. — Vol. 85, № 5. — P. 1186−1196.
- Mercadante S. Sleep disorders in advanced cancer patients: prevalence and factors associated / S. Mercadante, D. Girelli, A. Casuccio // Support. Care Cancer. 2004. — Vol. 12, № 5. P. 355−359.
- Mercadante S. The course of symptom frequency and intensity in advanced cancer patients followed at home / S. Mercadante, A. Casuccio, F. Fulfaro // J. Pain Symptom Manage. 2000. — Vol. 20, № 2. — P. 104−112.
- Merinsky О Palliative major amputation and quality of life in cancerpatients // Merinsky О, Kollender Y, Inbar M. et al. Acta Oncology. — 1997.—Vol. 36, № 2.—P. 151−157.
- Meuser T. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology / T. Meuser, C. Pietruck, L. Radbruch et al. // Pain. 2001. -Vol. 93, № 3.-P. 247−257.
- Meyers C.A. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients / C.A. Meyers, M.A. Weitzner, A.D. Valentine et al. // J. Clin. Oncol. 1998. — Vol. 16. — P. 2522−2527.
- Moinpour C. Cancer pain and quality of life / C. Moinpour, С Chapman, F. Georgiadou // Current and emerging issues in cancer pain: research and practice- Eds. C.R. Chapman, K. Foley. NY: Lippincott-Raven, 1993. P. 564−583.
- Moinpour С. M. Quality of life end points in cancer clinical trials: Review and recommendations / CM. Moinpour, P. Feigl, B. Metch et al. // Natl. Cancer Inst. 1989. — Vol. 81. — P. 485−495
- Moskowitz C.H. An update on the management of relapsed and refractory Hodgkin’s Lymphoma // Seminars in Oncology 2004, vol. 31 p. 54−59.
- Moskowitz C.H. Outcome of patients with primary refractory HD treated with high dose combined modality therapy and ASCT // British Journal of Haematology 2004, vol. 124 p. 645−652
- Mystakidou K. Influence of pain and quality of life on desire for hastened death in patients with advanced cancer / K. Mystakidou, E. Parpa, E. Katsouda et al. // Int. J. Palliat. Nurs. 2004. Vol. 10, № 10. P. 476 483.
- Nail L. Fatigue and weakness in cancer patients: the symptoms experience / L. Nail, M. Winningham // Semin. Oncol. Nurs. 1995. Vol. 11. P. 272−278.
- Nelson D. Self-report differentiation of anxiety and depression in chronic pain / D. Nelson, M. Novy // J. Personal Ass. 1997. — Vol. 69, № 2. -P. 392
- Nie J. Cancer pain and its influence on cancer patients' quality of life / J. Nie, S. Liu, L. Di et al. // Zhonghua Zhong Liu Za Zhi. 2000. — Vol. 22, № 5.-P. 432−434.
- Niscola P. Pain syndromes in haematological malignancies: an overview / P. Niscola, E. Arcuri, M. Giovannini et al. // Hematol. J. 2004. -Vol. 5, № 4. -P. 293−303.
- Norum J. Quality of life in survivors of Hodgkin’s disease // Qual. Life res.-vol. 61, 3. p. 367−374.
- Novik A. A. Early impact of chemotherapy on quality of life of malignant lymphoma patients / A.A. Novik, T.I. lonova, A.S. Povzun et al. // Annals Oncol. 2000. Vol. 23. — P. 182.
- O’Brien B. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and costs / B. O’Brien, J. Rusthoven, D.C. Tormey et al. // Can. Med. Assoc. J. 1993. Vol. 149. P. 296−302.
- Odonnell J.F. Insomnia in cancer patients / J.F. Odonnell // Clinical Cornstone. 2004. — Vol. 6, Suppl. ID. — P. S6-S14.
- Osoba D. Lessons learned from measuring health-related quality of life in oncology//! Clin. Oncol. — 1994. — Vol. 12. — P. 608−616.
- Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14: 671−679, 1996.
- Passik S.D. Depression in cancer patients: Recognition and treatment / S.D. Passik, M.V. McDonald, W. Dugan et al. // Medscape. Available at: http://www.medscape.com. Accessed March 1, 1997.
- Passik S.D. Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues / S.D. Passik, W.S. Breitbart // Cancer. -1996.-Vol. 78,1. Suppl. З.-Р. 615−626.
- Paul A. The age-adjusted international prognostic index predicts autologous stem cell transplant (ASCT) outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma // Hamlin, Andrew D Zelenetz et al. Blood Journal April 2003
- Portenoy R.K. Cancer pain: epidemiology and syndromes / R.K. Portenoy // Cancer. 1989. — Vol. 63. — P. 2298−2307.
- Portenoy R.K. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress / R.K. Portenoy, H.T. Thaler, A.B. Kornblith et al. // Eur. J. Cancer. -1994. Vol. 30A. — P. 1326−1336.
- Poulos A.R. Pain, mood disturbance, and quality of life in patients with multiple myeloma / A.R. Poulos, M.A. Gertz, V.S. Pankratz et al. // Oncol. Nurs. Forum. 2001. — Vol. 28, № 7. — P. 1163−1171.
- Ribeiro K.C. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas / K.C. Ribeiro, L.P. Kowalski, M.R. Latorre // Arch. Otolaryngol. Head. Neck. Surg. 2000. -Vol. 126, № 9.-P. 1079−1085.
- Ripamonti C. Management of dyspnea in advanced cancer patients / С Ripamonti // Support. Care Cancer. 1999. Vol. 7. P. 233−243.
- Schips L. Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients / L. Schips, K. Lipsky, R. Zigeuner et al. // Urology. 2003. — Vol. 62, № 6. -P. 1024−1028.
- Schumacher A. Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia / A. Schumacher, D. Wewers, A. Heinecke // Leuk. Res. 2002. — Vol. 26, № 4. — P. 355−362.
- Simpson M. The use of research to facilitate the creation of a hospital palliative care team / M. Simpson // Palliat. Med. 1991. — Vol. 5. — P. 122 129.
- Spilker B. Quality of life and pharmacoeconomics in clinical trials / Ed. Spilker B. 2nd Edition. — Philadelphia: New-York Lippincott-Raven, 1996. — 1259 p.
- Spilker B. Quality of life assessment in clinical trials- Ed. B. Spilker. NY, 1990.-24 p.
- Stalfelt A.M. The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain / A.M. Stalfelt, H. Brodin, S. Pettersson, A. Eklof// Leuk. Res. 2003. — Vol. 27. P. 481−488.
- Staquet M.J. Quality of life assessment in clinical trials- Ed. Staquet M.J. -Oxford, New York, Tokyo: Oxford University Press, 1998. p. 360
- Steven B. Clauser, et al. Patient-Reported Outcomes Assessment in Cancer Trials: Evaluating and Enhancing the Payoff to Decision Making // JCO Nov, vol.10, 2007: p 5049−5050
- Stone P. Fatigue in advanced cancer: A prospective controlled cross-sectional study / P. Stone, J. Hardy, K. Broadley et al. // Br. J. Cancer. -1999.-Vol. 79.-P. 1479−1486.
- Sugarbaker PH. Quality of life assessment of patient in extremity sarcoma clinical trials /Sugarbaker PH., Barofsky I., Rosenberg S.A., Gianola F.J. // Surgery. — 1982. — P. 13−23.
- Sullivan К. M. Long-term follow-up and quality of life after hematopoietic stem cell transplantation // The Journal of Rheumatology. — 1997. — Vol. 24. — Suppl. 48. — P. 46 — 52.
- Tesar G.E. Psychologic management of the hospitalized cardiac patients /Tesar G.E., Hackett T. R // J. Cardiopulm. Rehabil. — 1985—Vol. 5.— P.
- Twycross R. Risk factors for depression / R. Twycross, A. Wilcock // Symptom Management in Advanced Cancer. — 3d ed.- 2001. P. 192−196.
- Uematsu M. Stage IA Non-Hogdkin's lymphoma of the Waldeyer’s ring /Uematsu M., Kondo M., Hiramatsu H. //Acta Oncologica. — 1993. — Vol. 32, № 6. —P. 675−678
- Uematsu M. Defining the role of hemithorax Irradiation for thymomas is difficult/ Uematsu M., Steven E. // Jrn of Thorax Oncology, 3(1), vol. 1−2, January 2008.
- Vainio A. Prevalence of symptoms among patient with advanced cancer: an international collaborative study / A. Vainio, A. Auvinen // J. Pain Symptom Manage. -1996. Vol. 12. P. 3−10.
- Van Tulder M.W. The quality of life of long-term survivors of Hodgkin’s disease // semin. Hematol. 1997. — vol. 34, supp.2. — p. 4 — 12
- Vigano A. Quality of Life and Survival Prediction in Terminal Cancer. A Multicenter Study / A. Vigano, L. Donaldson, I. Higginson et al. // CANCER- Published Online: July 26. 2004.
- Vuorinen E. Pain as an early symptom in cancer / E. Vuorinen // Clin. J. Pain. 1993. Vol. 9. P. 272−278.
- Walsh D. The Symptoms of Advanced Cancer: Relationship to Age, Gender, and Performance Status in 1,000 Patients / D. Walsh, S. Donnelly, L. Rybicki // Support. Care Cancer. 2000. Vol. 8, № 3. — P. 0175−0179.
- Wang X.S. The effect of pain severity on health-related quality of life / X.S. Wang, C.S. Cleeland, TR Mendoza et al. // Cancer. 1999. -Vol. 86, № 9.-P. 1847−1855.
- Ware J. SF-36 health survey: manual and interpretation guide / J. Ware, K. Snow//Boston, 1993.-143 p.
- Ware J. SF-36 physical and mental summary scales: a user’s manual / J. Ware, M. Kosinski, S. Keller // Boston: The Health Institute, 1994.
- Ware J. The factor structure of the SF-36 health survey in 10 countries: results from the IQOLA Project / J. Ware, M. Kosinski, B. Gandek et al. Ill Clin. Epidemiol. 1998. Vol. 51, № 11. P. 1159−1165.
- Ware J. The status of health assessment 1994 / J. Ware // Public. Health.- 1995. Vol. 16. P. 327−354.
- Ware J.E. The MOS 36 item short form health survey (SF-36): Conceptual framework and item selection / J.E. Ware, CD. Sherbourne // Med. Care. — 1992. -№ 30. — P. 473−483.
- Watkins B.D. Issues and Challenges With Integrating Patient-Reported Outcomes in Clinical Trials Supported by the National Cancer Institute-Sponsored Clinical Trials Networks // JCO Nov vol. 10, 2007, p. 50 515 057
- Watkins B.D. Should Patient-Reported Outcomes Be Mandatory for Toxicity Reporting in Cancer Clinical Trials? // JCO Dec. vol. 1, 2007, p. 5345−5347
- Wisloff F. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group /Wisloff F, Hjorth M. // Br. J. Haematol. — 1997. — Vol. 97.1. P. 29 —37.
- World Health Organization: Constitution of the World Health Organization, in Handbook of Basic Documents. Geneva, 1948. 308. мм
- Yellen S. В., Cella D. F, Bolomi A. Quality of life in people with Hodgkin’s disease // Oncology. — 1993. — Vol. 7. — P. 41.
- Yellen S.B. Measuring Fatigue and other anemia-related symptoms with the Functional Assesment of Cancer Therapy (FACT) measurement system /Yellen S.B., Cella D.F. // J. Pain symptom Manage. 1997/ - Vol.13, 2 — p. 63 — 74.